New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM, ...
AZoLifeSciences on MSN
Microneedle patches may unlock safer, localized cancer immunotherapy
This review highlights the potential of natural polysaccharide microneedles in cancer immunotherapy, focusing on localized treatment and immune activation.
Researchers are uncovering how disrupted glutamatergic synapses drive diverse forms of intellectual disability, revealing new ...
Zacks Small Cap Research on MSN
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations
By Brad Sorensen, CFA NASDAQ:YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for ...
CAMBRIDGE, England and SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, ...
A single enzyme that can generate all four nucleoside triphosphates, the building blocks of ribonucleic acid (RNA), has been ...
Mounting evidence from research on nematodes to mice indicate that a father's environment, such as what he eats or if he is ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results